Cell Impact AB (publ) logo

CI B - Cell Impact AB (publ) Share Price

SEK49.2 5.2  11.8%

Last Trade - 26/10/21

Small Cap
Market Cap £218.5m
Enterprise Value £212.2m
Revenue £4.28m
Position in Universe 733rd / 1875
Unlock CI B Revenue
Relative Strength (%)
1m +1.11%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -35.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
1.93 1.88 1.74 6.82 12.0 29.3 97.0 165 +72.2%
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2021, Cell ImpactAB (publ) revenues increased from SEK11.9M to SEK33.3M. Netloss increased 52% to SEK38.5M. Revenues reflect Revenueincrease from SEK11.9M to SEK29.9M. Higher net lossreflects Labor Expenses increase of 84% to SEK25.8M(expense), Other External Expenses increase of 39% toSEK20.2M (expense), Depreciation & Amortization increase of57% to SEK4.4M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for CI B
Graphical History


CI B Revenue Unlock CI B Revenue

Net Income

CI B Net Income Unlock CI B Revenue

Normalised EPS

CI B Normalised EPS Unlock CI B Revenue

PE Ratio Range

CI B PE Ratio Range Unlock CI B Revenue

Dividend Yield Range

CI B Dividend Yield Range Unlock CI B Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CI B EPS Forecasts Unlock CI B Revenue
Profile Summary

Cell Impact publ AB is a Sweden-based company, which is active within the industrial sector. The Company develops and markets High Velocity Impact Units (HVI-U), which can be used to shape and shear material by using high kinetic energy. The energy is transferred into the material by an impact generating an extreme pressure within a fraction of a second. Its products have an impact energy from about 100 to 12,800 Joule. The HVI-U can be used for different purposes, such as embossing, creating coining type of patterns and replacing manufacturing methods, such as etching and milling. Additionally, the Company offers production of bipolar plates for fuel cells and heat exchanger plates, among others.

Last Annual December 31st, 2020
Last Interim June 30th, 2021
Public Since February 20, 2013
No. of Shareholders: 26,500
No. of Employees: 85
Sector Industrials
Industry Machinery, Equipment & Components
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 58,842,334
Free Float (0.0%)
Eligible for
CI B Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CI B
Upcoming Events for CI B
Friday 5th November, 2021
Q3 2021 Cell Impact AB (publ) Earnings Release
Friday 18th February, 2022
Q4 2021 Cell Impact AB (publ) Earnings Release
Frequently Asked Questions for Cell Impact AB (publ)
What is the Cell Impact AB (publ) share price?

As of 26/10/21, shares in Cell Impact AB (publ) are trading at SEK49.2, giving the company a market capitalisation of £218.5m. This share price information is delayed by 15 minutes.

How has the Cell Impact AB (publ) share price performed this year?

Shares in Cell Impact AB (publ) are currently trading at SEK49.2 and the price has moved by 82.19% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cell Impact AB (publ) price has moved by 37.36% over the past year.

What are the analyst and broker recommendations for Cell Impact AB (publ)?

Of the analysts with advisory recommendations for Cell Impact AB (publ), there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Cell Impact AB (publ) is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Cell Impact AB (publ) next release its financial results?

Cell Impact AB (publ) is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-06-30
What is the Cell Impact AB (publ) dividend yield?

Cell Impact AB (publ) does not currently pay a dividend.

Does Cell Impact AB (publ) pay a dividend?

Cell Impact AB (publ) does not currently pay a dividend.

When does Cell Impact AB (publ) next pay dividends?

Cell Impact AB (publ) does not currently pay a dividend.

How do I buy Cell Impact AB (publ) shares?

To buy shares in Cell Impact AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cell Impact AB (publ)?

Shares in Cell Impact AB (publ) are currently trading at SEK49.2, giving the company a market capitalisation of £218.5m.

Where are Cell Impact AB (publ) shares listed? Where are Cell Impact AB (publ) shares listed?

Here are the trading details for Cell Impact AB (publ):

Country of listing: Sweden
Exchange: STO
Ticker Symbol: CI B
What kind of share is Cell Impact AB (publ)?

Based on an overall assessment of its quality, value and momentum, Cell Impact AB (publ) is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Cell Impact AB (publ) share price forecast 2021?

Shares in Cell Impact AB (publ) are currently priced at SEK49.2. At that level they are trading at 78.64% premium to the analyst consensus target price of 0.00.

Analysts covering Cell Impact AB (publ) currently have a consensus Earnings Per Share (EPS) forecast of 0.1 for the next financial year.

How can I tell whether the Cell Impact AB (publ) share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cell Impact AB (publ). Over the past six months, the relative strength of its shares against the market has been -21.88%. At the current price of SEK49.2, shares in Cell Impact AB (publ) are trading at -8.55% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cell Impact AB (publ) PE Ratio?

We were not able to find PE ratio data for Cell Impact AB (publ).

Who are the key directors of Cell Impact AB (publ)?

Cell Impact AB (publ)'s management team is headed by:

Kjell Ostergren - DRC
Tord Andersson - IND
Par Teike - CEO
Achim Zeiss - OTH
Thomas Carlstrom - DRC
Baard Eilertsen - CHM
Harriet Lidh - DRC
Anders Oberg - CTO
Stefan Axellie - CFO
Daniel Vallin - COO
Who are the major shareholders of Cell Impact AB (publ)?

Here are the top five shareholders of Cell Impact AB (publ) based on the size of their shareholding:

Avanza Bank Holding AB Corporation
Percentage owned: 6.12% (3.59m shares)
L&G Hydrogen Economy UCITS ETF Fund Mutual Fund
Percentage owned: 5.49% (3.22m shares)
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund
Percentage owned: 5.49% (3.22m shares)
BNP Paribas Asset Management UK Limited Investment Advisor
Percentage owned: 5.13% (3.01m shares)
Östersjöstiftelsen Corporation
Percentage owned: 5.11% (3.00m shares)
Similar to CI B
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.